Celltrion is pushing into biosimilar market opportunities in China by setting up a joint venture with local player Nan Fung Group. Vcell Healthcare is aiming to market three of Celltrion’s biosimilars as well as exploring setting up a manufacturing plant in China.
Celltrion has struck a deal with Hong Kong’s Nan Fung Group to establish a local joint venture for developing and marketing biosimilars under the banner of Vcell Healthcare Limited.
“At the formation of the joint venture,” the companies announced, “Vcell Healthcare Limited has simultaneously signed a licensing agreement with...
Melinta Therapeutics has prevailed at the Federal Circuit in a patent dispute over its reformulated intravenous antibiotic Minocin, with the appeals court upholding both infringement and validity and leaving Nexus Pharmaceuticals barred from launching a generic until 2031.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
